SDS Biotech K.K. Reports Consolidated Earnings Results for the Second Quarter Ended June 30, 2015; Provides Consolidated Earnings Guidance and Dividend Guidance for the Fiscal Year Ending March 2016
The company provided consolidated earnings guidance for the fiscal year ending March 2016. For the year, the company expects to report net sales of ¥20,880 million, operating income of ¥2,170 million, ordinary income of ¥1,800 million and net income of ¥1,100 million or ¥140.46 per share.
The company provided dividend guidance for the year ended March 31, 2016. For the year the company expects to pay dividend of ¥15.00 as compared to ¥10.00 last year.